安达生物药物开发

Anda Biological Drug Development is a Beijing-based biotechnology company specializing in the research, development, and large-scale manufacturing of recombinant protein therapeutics. The company focuses on high-growth therapeutic areas including infectious diseases, endocrinology, and orthopedics. Its commercial portfolio is anchored by recombinant human interferon alpha-2b, marketed in various formulations such as gels and sprays for the treatment of HPV-related cervical conditions and viral infections. Additionally, Anda Bio is advancing a robust pipeline of biosimilars and innovative biologics, including teriparatide for osteoporosis and GLP-1 analogs for metabolic disorders. The firm operates integrated R&D centers and GMP-compliant manufacturing facilities to support its end-to-end drug development lifecycle.